Combination drug therapy for childhood brain tumors shows promise in laboratory models
In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
Read Original Article: Combination drug therapy for childhood brain tumors shows promise in laboratory models »
